Literature DB >> 28106973

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.

Neri A Álvarez-Villalobos1, Andrés M Treviño-Alvarez1, José G González-González2.   

Abstract

Entities:  

Year:  2016        PMID： 28106973     DOI： 10.1056/NEJMc1611289

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

1.  Glucagon-like peptide-1 (GLP-1) receptor agonists and cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of double-blind, randomized, placebo-controlled clinical trials.

Authors:  Jing Qin; Li Song
Journal:  BMC Endocr Disord       Date:  2022-05-12       Impact factor: 3.263

2.  GLP-1 alleviates NLRP3 inflammasome-dependent inflammation in perivascular adipose tissue by inhibiting the NF-κB signalling pathway.

Authors:  Xiangheng Chen; Qiuling Huang; Juling Feng; Zhongsheng Xiao; Xiaoling Zhang; Lei Zhao
Journal:  J Int Med Res       Date:  2021-02       Impact factor: 1.671

3.  Polymorphisms in the Glucagon-Like Peptide 1 Receptor (GLP-1R) Gene Are Associated with the Risk of Coronary Artery Disease in Chinese Han Patients with Type 2 Diabetes Mellitus: A Case-Control Study.

Authors:  Xiaowei Ma; Ran Lu; Nan Gu; Xiaowei Wei; Ge Bai; Jianwei Zhang; Ruifen Deng; Nan Feng; Jianping Li; Xiaohui Guo
Journal:  J Diabetes Res       Date:  2018-09-09       Impact factor: 4.011

4.  Liraglutide improves lipid metabolism by enhancing cholesterol efflux associated with ABCA1 and ERK1/2 pathway.

Authors:  Ya-Ru Wu; Xiao-Yun Shi; Chun-Yan Ma; Yue Zhang; Rui-Xia Xu; Jian-Jun Li
Journal:  Cardiovasc Diabetol       Date:  2019-11-09       Impact factor: 9.951

Review 5.  The Changing Landscape of Pharmacotherapy for Diabetes Mellitus: A Review of Cardiovascular Outcomes.

Authors:  Linda Wu; Jenny E Gunton
Journal:  Int J Mol Sci       Date:  2019-11-21       Impact factor: 5.923

Review 6.  Cardiac Autonomic Neuropathy in Obesity, the Metabolic Syndrome and Prediabetes: A Narrative Review.

Authors:  Scott M Williams; Aikaterini Eleftheriadou; Uazman Alam; Daniel J Cuthbertson; John P H Wilding
Journal:  Diabetes Ther       Date:  2019-09-24       Impact factor: 2.945

7.  Endothelin receptor antagonists for the treatment of diabetic nephropathy: A meta-analysis and systematic review.

Authors:  Li Zhang; Shuai Xue; Jie Hou; Guang Chen; Zhong-Gao Xu
Journal:  World J Diabetes       Date:  2020-11-15

Review 8.  Diabetic Gastroparesis: Principles and Current Trends in Management.

Authors:  Sathya Krishnasamy; Thomas L Abell
Journal:  Diabetes Ther       Date:  2018-06-22       Impact factor: 2.945

9.  Alogliptin improves survival and health of mice on a high-fat diet.

Authors:  Biao Zhu; Yixiang Li; Lingwei Xiang; Jiajia Zhang; Li Wang; Bei Guo; Minglu Liang; Long Chen; Lin Xiang; Jing Dong; Min Liu; Wen Mei; Huan Li; Guangda Xiang
Journal:  Aging Cell       Date:  2019-01-15       Impact factor: 9.304

10.  Asian Subpopulations May Exhibit Greater Cardiovascular Benefit from Long-Acting Glucagon-Like Peptide 1 Receptor Agonists: A Meta-Analysis of Cardiovascular Outcome Trials.

Authors:  Yu Mi Kang; Yun Kyung Cho; Jiwoo Lee; Seung Eun Lee; Woo Je Lee; Joong Yeol Park; Ye Jee Kim; Chang Hee Jung; Michael A Nauck
Journal:  Diabetes Metab J       Date:  2018-12-27       Impact factor: 5.376
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.